Charles Rhyee
Stock Analyst at TD Cowen
(0.95)
# 3,585
Out of 4,711 analysts
49
Total ratings
34.38%
Success rate
-10.99%
Average return
Main Sectors:
Stocks Rated by Charles Rhyee
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| CRL Charles River Laboratories International | Maintains: Hold | $203 → $227 | $185.77 | +22.19% | 5 | Nov 11, 2024 | |
| FTRE Fortrea Holdings | Maintains: Hold | $23 → $25 | $19.26 | +29.80% | 3 | Nov 11, 2024 | |
| TDOC Teladoc Health | Maintains: Hold | $9 → $8 | $9.44 | -15.25% | 6 | Oct 31, 2024 | |
| ICLR ICON Public Limited Company | Maintains: Buy | $369 → $285 | $207.51 | +37.34% | 3 | Oct 25, 2024 | |
| MEDP Medpace Holdings | Maintains: Buy | $413 → $372 | $337.28 | +10.29% | 3 | Oct 23, 2024 | |
| VEEV Veeva Systems | Maintains: Hold | $180 → $192 | $224.15 | -14.34% | 3 | Aug 29, 2024 | |
| GDRX GoodRx Holdings | Maintains: Buy | $14 → $16 | $4.44 | +260.36% | 7 | May 16, 2024 | |
| CAH Cardinal Health | Maintains: Market Perform | $88 → $90 | $118.28 | -23.91% | 1 | Aug 16, 2023 | |
| TALK Talkspace | Maintains: Outperform | $4 → $5 | $2.98 | +67.79% | 2 | May 3, 2023 | |
| AMWL American Well | Downgrades: Market Perform | $100 → $50 | $7.87 | +535.32% | 3 | Mar 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $251 | $197.27 | +27.24% | 1 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $70 → $56 | $4.64 | +1,106.90% | 2 | Oct 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $18 → $14 | $0.80 | +1,650.00% | 3 | Aug 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $48 → $50 | $11.41 | +338.21% | 2 | Jun 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $325 → $361 | $579.74 | -37.73% | 3 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $3,240 | $1.44 | +224,900.00% | 1 | Jul 16, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Market Perform | $35 | $21.76 | +60.85% | 1 | Feb 13, 2018 |
Charles River Laboratories International
Nov 11, 2024
Maintains: Hold
Price Target: $203 → $227
Current: $185.77
Upside: +22.19%
Fortrea Holdings
Nov 11, 2024
Maintains: Hold
Price Target: $23 → $25
Current: $19.26
Upside: +29.80%
Teladoc Health
Oct 31, 2024
Maintains: Hold
Price Target: $9 → $8
Current: $9.44
Upside: -15.25%
ICON Public Limited Company
Oct 25, 2024
Maintains: Buy
Price Target: $369 → $285
Current: $207.51
Upside: +37.34%
Medpace Holdings
Oct 23, 2024
Maintains: Buy
Price Target: $413 → $372
Current: $337.28
Upside: +10.29%
Veeva Systems
Aug 29, 2024
Maintains: Hold
Price Target: $180 → $192
Current: $224.15
Upside: -14.34%
GoodRx Holdings
May 16, 2024
Maintains: Buy
Price Target: $14 → $16
Current: $4.44
Upside: +260.36%
Cardinal Health
Aug 16, 2023
Maintains: Market Perform
Price Target: $88 → $90
Current: $118.28
Upside: -23.91%
Talkspace
May 3, 2023
Maintains: Outperform
Price Target: $4 → $5
Current: $2.98
Upside: +67.79%
American Well
Mar 23, 2023
Downgrades: Market Perform
Price Target: $100 → $50
Current: $7.87
Upside: +535.32%
Dec 6, 2022
Initiates: Outperform
Price Target: $251
Current: $197.27
Upside: +27.24%
Oct 20, 2022
Maintains: Outperform
Price Target: $70 → $56
Current: $4.64
Upside: +1,106.90%
Aug 16, 2022
Maintains: Outperform
Price Target: $18 → $14
Current: $0.80
Upside: +1,650.00%
Jun 21, 2022
Maintains: Outperform
Price Target: $48 → $50
Current: $11.41
Upside: +338.21%
Apr 18, 2022
Maintains: Outperform
Price Target: $325 → $361
Current: $579.74
Upside: -37.73%
Jul 16, 2020
Initiates: Outperform
Price Target: $3,240
Current: $1.44
Upside: +224,900.00%
Feb 13, 2018
Initiates: Market Perform
Price Target: $35
Current: $21.76
Upside: +60.85%